MarketCap
Facebook
X
Telegram
Apellis Pharmaceuticals Langfristiger Schuldenstrom | APLS
Langfristiger Schuldenstrom Jährlich Apellis Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.09 M | 6.75 M | 6.44 M | 5.62 M | 4.12 M | 3.68 M | 2.61 M | 1.67 M | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.09 M | 1.67 M | 4.75 M |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Happiness Biotech Group Limited
HAPP
|
155 K | - | 1.35 % | $ 17.8 M |  China |
 |
Novavax
NVAX
|
9.88 M | $ 10.15 | -6.8 % | $ 1.64 B |  USA |
 |
Hepion Pharmaceuticals
HEPA
|
116 K | - | -18.79 % | $ 39.3 K | USA |
 |
Hoth Therapeutics
HOTH
|
5.68 K | - | - | $ 18.8 M | USA |
 |
IMARA
IMRA
|
399 K | - | 15.96 % | $ 663 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
1.62 M | - | - | $ 1.45 B |  Britain |
 |
KemPharm
KMPH
|
419 K | - | -0.34 % | $ 200 M | USA |
 |
Kezar Life Sciences
KZR
|
2.33 M | - | - | $ 53.3 M | USA |
 |
Lixte Biotechnology Holdings
LIXT
|
595 K | - | - | $ 63.4 M | USA |
 |
Magenta Therapeutics
MGTA
|
367 K | - | -7.74 % | $ 41.6 M | USA |
 |
NovaBay Pharmaceuticals
NBY
|
422 K | - | - | $ 11.3 M | USA |
 |
NeuroBo Pharmaceuticals
NRBO
|
68 K | - | 0.43 % | $ 12 M | USA |
 |
Opthea Limited
OPT
|
93 K | - | - | $ 1.2 B |  Australia |
 |
Verastem
VSTM
|
535 K | $ 8.74 | 0.52 % | $ 606 M | USA |
 |
BiomX
PHGE
|
1.44 M | $ 1.85 | 14.2 % | $ 3.02 M |  Israel |
 |
Pieris Pharmaceuticals
PIRS
|
202 K | - | -15.58 % | $ 1.22 B |  Germany |
 |
Plus Therapeutics
PSTV
|
56 K | - | - | $ 301 M | USA |
 |
Pluristem Therapeutics
PSTI
|
996 K | - | -1.9 % | $ 33.3 M | Israel |
 |
Qualigen Therapeutics
QLGN
|
241 K | - | 5.59 % | $ 1.16 M | USA |
|
Qilian International Holding Group Limited
QLI
|
241 K | - | -6.08 % | $ 184 M | China |
 |
Cassava Sciences
SAVA
|
104 K | - | - | $ 110 M | USA |
 |
Selecta Biosciences
SELB
|
4.15 M | - | -8.69 % | $ 126 M | USA |
 |
Sangamo Therapeutics
SGMO
|
1.7 M | - | - | $ 50.4 M | USA |
 |
Sensei Biotherapeutics
SNSE
|
1.37 M | - | - | $ 17.5 M | USA |
 |
Sonnet BioTherapeutics Holdings
SONN
|
46.6 K | - | - | $ 826 K | USA |
 |
Synthetic Biologics
SYN
|
549 K | - | 1.32 % | $ 16.2 M | USA |
 |
Synlogic
SYBX
|
4.78 M | - | - | $ 7.07 M | USA |
 |
Virios Therapeutics, LLC
VIRI
|
56.8 K | - | 2710.01 % | $ 72.9 M | USA |
 |
Vallon Pharmaceuticals
VLON
|
56 K | - | -6.47 % | $ 5.76 M | USA |
 |
Vaxart
VXRT
|
2.53 M | - | -25.06 % | $ 46.3 M | USA |
 |
XOMA Corporation
XOMA
|
2.46 M | - | - | $ 485 M | USA |
 |
Repare Therapeutics
RPTX
|
1.84 M | - | - | $ 112 M |  Canada |
 |
Sesen Bio
SESN
|
832 K | - | 7.29 % | $ 127 M | USA |
|
Windtree Therapeutics
WINT
|
508 K | - | - | $ 26.8 M | USA |
 |
SQZ Biotechnologies Company
SQZ
|
6.56 M | - | 57.95 % | $ 12.8 M | USA |
 |
MEI Pharma
MEIP
|
1.43 M | - | 10.43 % | $ 20.5 M | USA |
 |
Palatin Technologies
PTN
|
158 K | - | - | $ 13 M | USA |
 |
Lyra Therapeutics
LYRA
|
4.82 M | - | - | $ 24.9 M | USA |
 |
Brickell Biotech
BBI
|
49 K | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Therapeutics
APLT
|
406 K | - | - | $ 8.42 M | USA |
 |
ESSA Pharma
EPIX
|
124 K | - | - | $ 8.86 M | Canada |
 |
Generation Bio Co.
GBIO
|
13 M | - | - | $ 344 M | USA |